Top Feature

Dec 14, 2016
Pharmaceutical Executive
Pharm Exec sits down with veteran journalist Paula Apsell, the driving force behind the long-running PBS science series NOVA for some straightforward advice to the biopharma industry.
Dec 12, 2016
Bill Drummy reviews the "techno-optimistic" highlights of this year's Exponential Medicine conference in San Diego.
Dec 07, 2016
Pharmaceutical Executive
The industry is readying for a leap into a new age of complex therapies. But there are deep chasms to cross in bridging the potential with reality.
Nov 18, 2016
Pharmaceutical Executive
The steps to stay ahead of the looming shakeup in pharma. Peter Gassner reports.
Nov 11, 2016
Pharmaceutical Executive
Biopharma companies are increasingly leveraging product portfolios to own and dominate strategically important therapeutic areas,, writes Stan Bernard.
Nov 09, 2016
Pharmaceutical Executive
Jeremy Desai, CEO of Apotex, Canada’s largest producer of generic drugs, on how independent companies can survive in an era of consolidation and growing competition.
Nov 09, 2016
Pharmaceutical Executive
Loss of exclusivity (LOE) doesn’t have to be the death knell for branded drug revenue streams. The key approaches to preserving meaningful value well into the post-patent-loss future are outlined.
Oct 24, 2016
Pharmaceutical Executive
Pharm Exec examines the evolving role of the chief financial officer as not just a numbers and bottom-line risk manager but an integral contributor to overall corporate strategy and close partner to the CEO.
Oct 24, 2016
Pharmaceutical Executive
A practical roadmap for pharma brand teams in avoiding the pitfalls in statistical thinking when appraising and presenting data.
Oct 13, 2016
Pharmaceutical Executive
Answer 12 key questions to determine if your brand team is leveraging today’s winning competitive strategies and actions.
native1_300x100
lorem ipsum